OTNFDA Class 2 · 21 CFR 878.3300 · implantable

Mesh, Surgical, Synthetic, Urogynecologic, For Stress Urinary Incontinence, Retropubic Or Transobturator

Device family · General, Plastic Surgery

Automated profile from regulatory + adverse-event registries · AI-reviewed · expert clinical sign-off in progress — not yet independently verified.
FDA clearances
65
Manufacturers
11
Flagged signals
20
Adverse-event reports
38,016

Code matrix

FDA product codeOTN
Device classClass 2
Regulation21 CFR 878.3300
GMDN— (crosswalk pending)
ImplantableYes
Life-sustainingNo

Adverse-event signals

Public · always free

MAUDE disproportionality (PRR), flagged where PRR ≥ 2, χ² ≥ 4, count ≥ 3.

Event typeYearReportsPRRχ²
Death20162918.8476
Death20157411.3693
Death2007106.541
Death200995.832
Death201195.832
Death201385.223
Death2014304.682
Death200674.516
Death200863.910
Death201453.26
Death2011192.922
Injury202152.66
Injury20133732.5558
Injury20135902.5880
Injury2013292.541
Death2010162.512
Injury2013922.4114
Injury2013502.252
Death2016142.18
Death2012142.18

Device-level recall linkage pending an FDA-recalls product-code re-ingest. Class 2 family · 38,016 total adverse-event reports.

Manufacturer landscape

ManufacturerClearancesLatestConcern
AMERICAN MEDICAL SYSTEMS, INC.132013
Caldera Medical, Inc.72021
Ethicon, Inc.62020
Mentor Corp.22004
SOFRADIM PRODUCTION22004
C.R. Bard, Inc.22010
Boston Scientific22004
BOSTON SCIENTIFIC CORPORATION220230.14
Coloplast A/S12011
Uroplasty, Inc.12005
Boston Scientific Corp12012

Concern score lights up where a maker maps to a scored entity (depth fast-follow).

Recent FDA clearances

Advantage Ultra System, Advantage Fit Ultra System, Lynx Ultra System · Boston Scientific Corporation510(k) · 2023-06-29
ArcSP Suprapubic Sling System · Urocure, LLC510(k) · 2022-09-21
ArcTO Transobturator Sling System · Urocure, LLC510(k) · 2022-09-15
Desara TV EZ 3.0 System, Desara Blue TV EZ 3.0 System, Desara TV EZ 2.7 System, Desara Blue TV EZ 2.7 System · Caldera Medical, Inc.510(k) · 2021-11-10
Advantage Ultra System, Advantage Fit Ultra System, Lynx Ultra System · Boston Scientific Corporation510(k) · 2021-07-21
Athena Surgical RMUS System · Athena Surgical, LLC510(k) · 2021-04-12
GYNECARE TVT™ System, GYNECARE TVT™ with Abdominal Guides System, GYNECARE TVT™ Introducer and Catheter Guide, GYNECARE TVT EXACT™ Continence System and Trocar, GYNECARE TVT™ Obturator System and Passers and Winged Guide, GYNECARE TVT ABBREVO™ Continence System and Passers and Winged Guide · ETHICON, Inc.510(k) · 2020-09-17
ArcTV Transvaginal Sling System · Urocure, LLC510(k) · 2019-02-07
Desara TV, Desara Blue TV · Caldera Medical, Inc.510(k) · 2017-01-11
DESARA BLUE OV, DESARA BLUE SS · Caldera Medical510(k) · 2014-07-01
SPARC SYSTEM AND MONARC, MONARC, AND MONARC C SYSTEMS · American Medical Systems510(k) · 2013-12-05
RETROARC RETROPUBIC SLING SYSTEM · American Medical Systems, Inc.510(k) · 2013-11-20
DESARA MESH, DESARA BLUE · Caldera Medical, Inc.510(k) · 2013-09-23
GYNECARE TVT EXACT CONTINENCE SYSTEM · ETHICON, Inc.510(k) · 2013-08-23
DESARA SL · Caldera Medical, Inc.510(k) · 2013-02-19
BLUE SUI SLING · Boston Scientific Corp510(k) · 2012-10-10
KIM · Neomedic International S.L.510(k) · 2011-12-20
DESARA MESH · Caldera Medical, Inc.510(k) · 2011-09-30
GMD UNIVERSAL URINARY INCONTINENCE SLING · Generic Medical Device, Inc.510(k) · 2011-06-30
SUPRIS RETROPUBIC SLING SYSTEM · Coloplast A/S510(k) · 2011-06-24
GYNECARE TVT ABBREVO CONTINENCE SYSTEM · ETHICON, Inc.510(k) · 2010-07-01
GMD UNIVERSAL URINARY INCONTINENCE SLING, MODEL 1012 · Generic Medical Devices, Inc.510(k) · 2010-06-18
DESARA MESH MODEL: CAL-DS01 · Caldera Medical, Inc.510(k) · 2010-05-20
ALIGN AND ALIGN TO URETHRAL SUPPORT SYSTEMS · C.R. Bard, Inc.510(k) · 2010-05-07
GYNECARE TVT EXACT CONTINENCE SYSTEM · ETHICON, Inc.510(k) · 2010-03-16

Sources: FDA 510(k)/PMA · openFDA MAUDE · FDA device classification · MedevIQ manufacturer-canonical. Registry data, AI-reviewed; expert clinical sign-off in progress.

Early access

MedevIQ is in private preview.

We're onboarding hospitals, manufacturers, regulators and research teams in waves. Tell us how you'd use MedevIQ and we'll get back within a working week.

We'll reply within a working week.

Access by invitation while v1 finalizes.